Table 8: Abundance of butyrate-producing bacteria (in %) among diabetes patients with and without cardiovascular complications (CVCs).
| Bacteria name | Unit | Patients without CVCs | Patients with CVCs | p* |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | |||
| Roseburia | % | 0.03 ± 0.05£ | 0.02 ± 0.02 | 0.32 |
| Faecalibacterium | % | 4.88 ± 4.25£ | 3.57 ± 3.13 | 0.18 |
| Eubacterium | % | 3.96 ± 3.16£ | 3.52 ± 3.24 | 0.59 |
| Akkermansia | % | 1.35 ± 2.04£ | 1.01 ± 2.1 | 0.52 |
| Bifidobacterium | % | 0.74 ± 0.87£ | 0.56 ± 0.57 | 0.35 |
| Ruminococcus | % | 6.09 ± 4.44 | 6.99 ± 4.59£ | 0.44 |
| Butyrivibrio | % | 0.05 ± 0.19£ | 0.02 ± 0.06 | 0.42 |
| Coprococcus | % | 0.85 ± 1.39£ | 0.76 ± 1.27 | 0.79 |
| Grand average | % | 2.24 ± 2.37£ | 2.06 ± 2.45 | 0.77 |
*p: Probability value; The arrows represent average differences even if statistically not significant; SD: Standard Deviation.